Latest Announcements

Sasken Technologies Limited has announced an earnings call to discuss its financial results for the quarter and half year ended September 30, 2026. The call will be held on October 29, 2026, at 3:00 PM IST and will include a management commentary and an interactive question-and-answer session.

Shanthi Gears Limited has submitted its financial results for the quarter ended September 30, 2026, with revenue of ₹ 127.98 Crores and profit before tax of ₹ 20.20 Crores. The company achieved its highest-ever order booking of ₹ 192 Crores in Q2 FY27.

TCPL Packaging Limited has informed the Exchange about the schedule of a conference call to be held on November 06, 2026, to discuss Q2 & H1 FY2027 results.

Modis Navnirman Limited has informed the Exchange about the link for the audio recording of the Earnings Conference Call held on October 26, 2026, where the management discussed the Company's Unaudited Standalone and Consolidated Financial Results ending September 30, 2026.

Dalmia Bharat Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, and declared an interim dividend at Rs. 4/- (200%) per equity share.

Sumitomo Chemical India Limited has submitted its unaudited financial results for the quarter and half-year ended 30th September, 2026, along with limited review reports from auditors BSR & Co. LLP.

Bank of Maharashtra has released its investor presentation for the quarter and half-year ended on 30th September 2026, highlighting sustained economic growth, increased profitability, and improved asset quality.

Kansai Nerolac Paints Limited has informed the Exchange about the schedule of a conference call to discuss Q2 FY 2026-27 Financial Results on November 5, 2026.

Oracle Financial Services Software Limited has informed the Exchange about the copies of the newspaper publications of financial results for the three and six month period ended September 30, 2026.

KEC International Limited will hold an Earnings Conference Call on November 03, 2026, to discuss its unaudited financial results for the quarter and half year ended September 30, 2026.

Bank of Maharashtra has announced its financial results for the quarter and half-year ended 30.09.2026, showing a 25.16% growth in total global business and a 41.42% increase in net profit.

Mankind Pharma Limited has announced its financial results for Q2 and H1 FY27, reporting a 17% YoY growth in revenue, 27% YoY growth in EBITDA, and 38% YoY growth in PAT. The company's domestic business grew 16% YoY, driven by strong double-digit growth in both Mankind and BSV specialty business.

Bank of Maharashtra has informed the Exchange about Presentation of Investor Presentation with regard to the Financial Results of the Bank for the quarter and half-year ended on 30th September, 2026.

Crizac Limited has informed the Exchange about Schedule of meet of the investors and analysts to be held on Monday 2nd November, 2026 at 12.00 Noon to discuss the company’s results for 2QFY27.

Mankind Pharma Limited has announced its financial results for Q2 & H1 FY27, with revenue growth of 17% YoY, EBITDA up by 27% YoY, and PAT up by 38% YoY. Domestic business delivered robust growth of 16% YoY, driven by strong double-digit growth in both Mankind and BSV specialty business.

Bank of Maharashtra has submitted its unaudited financial results for the quarter and half-year ended September 30, 2026, which were approved by the Board of Directors. The results will be available on the bank's website.

Stove Kraft Limited has informed the Exchange about a conference call with investors and analysts to discuss unaudited financial results for the quarter and half year ended 30 September 2026.

Vidhi Specialty Food Ingredients Limited has announced its Unaudited Financial Results for the quarter and half year ended September 30, 2026, and has also made an investor presentation on the same. The company has highlighted its strong business outlook, rationalization model, and expansion into new sectors.

Cyber Media (India) Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, to the Exchange, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mankind Pharma Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, and approved the Scheme of Arrangement for the amalgamation of its wholly owned subsidiaries with the company.